A reduction in the exercise price, or an extension of the expiry date would obviously both help the cause of the options, and change the comparative calculations.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025